Why the MedAdvisor (ASX:MDR) share price jumped 9% on Friday

The MedAdvisor Ltd (ASX:MDR) share price was a strong performer on Friday and jumped as much as 9% higher. Here's why…

| More on:
a smiling doctor looks at her computer screen with medical imaging X-rays on a light screen in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MedAdvisor Ltd (ASX: MDR) share price was a strong performer on Friday.

The medication management platform provider's shares were up as much as 9% to 42.5 cents at one stage.

The MedAdvisor share price ultimately ended the day 6.5% higher at 41.5 cents.

Why did the MedAdvisor share price shoot higher?

Investors were buying MedAdvisor's shares on Friday after the release of a positive announcement relating to its US activities.

According to the release, the company has extended its US digital secure messaging pilot with a major top 10 global pharmaceutical company. It will now continue through until the end of calendar year 2021.

Management advised that the program, which is a partnership with its newly acquired Adheris business, is worth US$800K (A$1.1 million) based on estimates of patient reach. Though, this is incremental to any revenue earned in 2020 from the previously announced pilot.

The partnership between Adheris and MedAdvisor was designed to bring secure digital health programs to a subset of the Adheris network. This network extends to 25,000 pharmacies and can reach 1 in 2 Americans on an opt-out basis. The company expects the program to run through up to 25% of the Adheris network.

The product, which is marketed by Adheris in the US as inMotion, sends a text message to patients on a specific and targeted drug to allow a patient to then access a secure website with important information about their medication.

The pharmaceutical company undertaking the pilot originally went live with five products and has since added a sixth product.

Adheris President and incoming MedAdvisor US President & CEO, John Ciccio, commented "We've set up a strong pipeline with a range of top tier pharmaceutical companies this quarter. Our integrated, digital product which was developed between Adheris and MedAdvisor is receiving positive feedback in the market with this pilot program renewing for increased scale year on year."

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 3 April 2025

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of MedAdvisor. The Motley Fool Australia has recommended MedAdvisor. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were off to a flying start this Monday.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why DroneShield, Fiducian, Neuren, and Newmont shares are storming higher

These shares are starting the week on a high. But why?

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors had a rough end to a tough week this Friday.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was once again back to the races for investors today.

Read more »

Five happy friends enjoying a party.
Share Gainers

5 ASX 200 shares leading the charge higher in Thursday's rocketing market

It’s a great day to be invested in ASX 200 shares today. Especially in these five!

Read more »

Ecstatic man giving a fist pump in an office hallway.
Share Gainers

Why Boss Energy, Netwealth, Woodside, and Zip shares are racing higher today

These shares are rebounding more than most on Thursday. But why?

Read more »

A concerned man looking at his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

The relief from yesterday wasn't to last.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher

These shares are avoiding the market sell off today. But why?

Read more »